204 related articles for article (PubMed ID: 36033394)
1. FABP6 Expression Correlates with Immune Infiltration and Immunogenicity in Colorectal Cancer Cells.
Lian W; Wang Z; Ma Y; Tong Y; Zhang X; Jin H; Zhao S; Yu R; Ju S; Zhang X; Guo X; Huang T; Ding X; Peng M
J Immunol Res; 2022; 2022():3129765. PubMed ID: 36033394
[TBL] [Abstract][Full Text] [Related]
2. High expression of FABP4 and FABP6 in patients with colorectal cancer.
Zhang Y; Zhao X; Deng L; Li X; Wang G; Li Y; Chen M
World J Surg Oncol; 2019 Oct; 17(1):171. PubMed ID: 31651326
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma.
Yang H; Zhao L; Zhang Y; Li FF
Cancer Med; 2021 Aug; 10(16):5696-5711. PubMed ID: 34258887
[TBL] [Abstract][Full Text] [Related]
4. Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription.
Zuo Q; Xu Q; Li Z; Luo D; Peng H; Duan Z
Anticancer Drugs; 2023 Nov; 34(10):1171-1182. PubMed ID: 37067981
[TBL] [Abstract][Full Text] [Related]
5. Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers.
Lin CH; Chang HH; Lai CR; Wang HH; Tsai WC; Tsai YL; Changchien CY; Cheng YC; Wu ST; Chen Y
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216267
[TBL] [Abstract][Full Text] [Related]
6. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Analysis Reveals the Immune Infiltration Profiles in Cervical Cancer and Identifies KRT23 as an Immunotherapeutic Target.
Li X; Cheng Y; Cheng Y; Shi H
Front Oncol; 2022; 12():779356. PubMed ID: 35814465
[TBL] [Abstract][Full Text] [Related]
8. SLC4A4 moulds the inflammatory tumor microenvironment and predicts therapeutic expectations in colorectal cancer.
Xiang D; Li H; Pan J; Chen Y
Curr Med Chem; 2024 Jan; ():. PubMed ID: 38310390
[TBL] [Abstract][Full Text] [Related]
9. CMTM6 and PD-L1 coexpression is associated with an active immune microenvironment and a favorable prognosis in colorectal cancer.
Peng QH; Wang CH; Chen HM; Zhang RX; Pan ZZ; Lu ZH; Wang GY; Yue X; Huang W; Liu RY
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33579737
[TBL] [Abstract][Full Text] [Related]
10. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
11. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
12. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
13. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas.
Prayugo FB; Kao TJ; Anuraga G; Ta HDK; Chuang JY; Lin LC; Wu YF; Wang CY; Lee KH
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680577
[TBL] [Abstract][Full Text] [Related]
14. Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting.
Aristin Revilla S; Kranenburg O; Coffer PJ
Front Immunol; 2022; 13():903564. PubMed ID: 35874729
[TBL] [Abstract][Full Text] [Related]
15. Adenoma to carcinoma: A portrait of molecular and immunological profiles of colorectal sporadic tumors.
Elsayed I; Li L; Sheahan K; Moran B; Bakheit S; Wang X
Int Immunopharmacol; 2021 Nov; 100():108168. PubMed ID: 34562842
[TBL] [Abstract][Full Text] [Related]
16. Subtyping of microsatellite stability colorectal cancer reveals guanylate binding protein 2 (GBP2) as a potential immunotherapeutic target.
Wang H; Zhou Y; Zhang Y; Fang S; Zhang M; Li H; Xu F; Liu L; Liu J; Zhao Q; Wang F
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383115
[TBL] [Abstract][Full Text] [Related]
17. Immune infiltration profiling in gastric cancer and their clinical implications.
Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid binding protein 6 is overexpressed in colorectal cancer.
Ohmachi T; Inoue H; Mimori K; Tanaka F; Sasaki A; Kanda T; Fujii H; Yanaga K; Mori M
Clin Cancer Res; 2006 Sep; 12(17):5090-5. PubMed ID: 16951225
[TBL] [Abstract][Full Text] [Related]
19. Molecular subtyping and the construction of a predictive model of colorectal cancer based on ion channel genes.
Ai LJ; Li GD; Chen G; Sun ZQ; Zhang JN; Liu M
Eur J Med Res; 2024 Apr; 29(1):219. PubMed ID: 38576045
[TBL] [Abstract][Full Text] [Related]
20. NAV3 Is a Novel Prognostic Biomarker Affecting the Immune Status of the Tumor Microenvironment in Colorectal Cancer.
Li M; Wang Z; Dong S; Xu Y
J Immunol Res; 2022; 2022():8337048. PubMed ID: 35812247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]